Navigation Links
New initiative to develop a system that controls prosthetic limbs naturally
Date:11/17/2010

Using beams of light to allow amputees not only to control but also to feel the movement of prosthetic limbs is the ambitious goal of a new $5.6 million Department of Defense initiative.

The Defense Advanced Research Projects Agency is tapping the new and rapidly growing field of "neurophotonics" to overcome one the biggest technical obstacles to designing prosthetic arms and legs that work naturally: providing a two-way link with the peripheral nervous system.

An interdisciplinary Vanderbilt team including biomedical engineers Duco Jansen and Anita Mahadevan-Jansen, and neurosurgeon Peter Konrad will play a critical role in the two-year effort, which is led by a research team at Southern Methodist University and includes collaborators at Case Western Research University, University of Texas, Dallas and the University of North Texas and several industrial partners, including Lockheed Martin, Texas Instruments and National Instruments.

Such a system must have two major capabilities: It must sense the activity of motor nerves in order to direct the motion of the prosthetic device and it must stimulate sensory nerves to provide the amputee's brain with the feedback it needs to control the device's movements.

Five years ago, the Vanderbilt trio helped kick start the neurophotonics field when it demonstrated that a low-power infrared laser beam can stimulate peripheral nerves in a live rat. Since then they have shown that laser stimulation is repeatable, can be done without damaging or overheating the nerve cells and can be focused tightly enough to stimulate individual neurons, a precision that is not possible with electrical stimulation. The Vanderbilt team is heading up the nerve stimulation portion of the project.

"I'm pretty confident we can deliver on the stimulation side," said Jansen, who is a professor of biomedical engineering. "The sensing side is at an earlier stage of development and there are numerous engineering challe
'/>"/>

Contact: David F. Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. OSU, Oxford, others launch citizen scientist climate modeling initiative
2. European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives
3. Syracuse University partners with Arden-Fox to advance DODs Net Zero Energy Initiative
4. SRNL, Chernobyl Laboratory collaborate on research initiatives
5. New global coffee research initiative announced
6. JPMorgan Chase & Co., Invests $25,000 to Support Bring Me A Books San Jose Elementary School Library Initiative
7. Peak P? Phosphorus, food supply spurs Southwest initiative
8. Networking initiative to support interdisciplinary research
9. IEEE-USA President praises US job growth initiative by Invest in America Alliance
10. Resurrected ParticipACTION initiative success underpinned by brand, organizations
11. Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New initiative to develop a system that controls prosthetic limbs naturally
(Date:7/30/2014)... biologists, led by Clemson University associate professor Andrew S. ... will pave the way for novel anti-fouling paint for ... and industrial applications. , The team,s findings, published in ... larval stage of barnacles that attaches to a wide ... material that acts as an underwater heavy-duty adhesive. , ...
(Date:7/30/2014)... Portland Press Limited today announced an across-the-board increase ... , The 2013 InCites Journal Citation Reports (Thomson ... Biochemical Journal , Essays in Biochemistry ... Bioscience Reports all received increases in their ... Biochemical Society and published by Portland Press Limited. ...
(Date:7/30/2014)... A professor from Wayne State University,s College of ... National Science Foundation for the project, "Nanoparticle-directed synthesis ... National Science Foundation, nanotechnology is the creation and ... novel properties and functions. A major bottleneck in ... methods that connect different functional materials into one ...
Breaking Biology News(10 mins):Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... have created the first three-dimensional living tissue model, complete ... therapeutics to combat brain tumors. The 3-D model gives ... tissue cultures. The researchers created a glioma, or ... surrounds it. In a series of experiments, the team ...
... have succeeded in changing the genetic material of cancer ... in nanosurgery opens the door to new medical applications, ... A light scalpel to treat cancerous cells, The ... team uses a femtosecond laser (a laser with ultra-short ...
... Resolving the world,s major challenges whether climate change, ... scarcity requires a sweeping shift in our approach ... leading scientists told European policy makers today during ... and Societal Challenges for our Unstable Earth" (RESCUE). ...
Cached Biology News:Researchers make living model of brain tumor 2Europe needs a 'RESCUE' revolution 2Europe needs a 'RESCUE' revolution 3
(Date:7/30/2014)... , July 30, 2014  Orexigen Therapeutics, Inc. (Nasdaq: ... the Day 180 List of Outstanding Issues (LOI) from ... Human Use (CHMP) for the NB32 Marketing Authorization Application ... is an investigational drug candidate being evaluated for weight ... Day 120 time point were adequately addressed by the ...
(Date:7/30/2014)...  AtheroNova Inc. (OTCBB: AHRO), a biotech company ... to safely regress atherosclerotic plaque and improve lipid ... CardioNova, has accomplished first dosing of subjects for ... compound, AHRO-001.  This Phase 1b trial will be ... trial completed in February 2014, in which patients ...
(Date:7/30/2014)... July 30, 2014 Vala Sciences ... U.S. Environmental Protection Agency (EPA). This new contract ... toxicity models, including tests designed to assess the ... the formation of connections between neurons (synapses), which ... and synapse formation by environmental pollutants likely contributes ...
(Date:7/29/2014)... July 30, 2014 SoundConnect ... collaboration company, is proud to announce the strategic ... positions in their Boston, Charleston and Atlanta offices. ... the increased demand for hosted solutions, collaboration and ... and reduce cost. , SoundConnect was founded in ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3SoundConnect Organization and Culture is Evolving 2
... July 14 Bio-Optronics, Inc., a leader in healthcare workflow ... software solution that can simultaneously handle the most intricate scheduling ... staff schedules. , , Physician ... , Bio-Optronics President & CEO, ...
... , HALIFAX, NS, July 14 /PRNewswire/ - ImmunoVaccine ... entered into an agreement to exclusively license seven ... company. These proprietary antigens specifically target breast, ovarian ... antigens with its DepoVax(TM) delivery platform to develop ...
... , , TAMPA, Fla., July ... on the research and development of cancer immunotherapies, announces that the ... its dendritic cell therapy. , , ... I/II clinical trial testing the safety and efficacy of its immunotherapy ...
Cached Biology Technology:NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling 2ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 3